Prestige Brand is a drug manufacturers - specialty & generic business based in the US. Prestige Brand shares (PBH) are listed on the NYSE and all prices are listed in US Dollars. Prestige Brand employs 570 staff and has a trailing 12-month revenue of around $1.1 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $70.40 |
|---|---|
| 52-week range | $56.34 - $75.31 |
| 50-day moving average | $67.16 |
| 200-day moving average | $65.02 |
| Wall St. target price | $80.20 |
| PE ratio | 17.0839 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $4.17 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $70.4 from 2024-07-25
| 1 week (2024-07-19) | -1.18% |
|---|---|
| 1 month (2024-06-27) | 1.12% |
| 3 months (2024-04-26) | -0.10% |
| 6 months (2024-01-26) | 11.85% |
| 1 year (2023-07-27) | 8.98% |
|---|---|
| 2 years (2022-07-27) | 16.54% |
| 3 years (2021-07-27) | 33.66% |
| 5 years (2019-07-26) | 110.09% |
Valuing Prestige Brand stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Prestige Brand's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Prestige Brand's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Prestige Brand shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Prestige Brand's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2785. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Prestige Brand's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Prestige Brand's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $373.1 million.
The EBITDA is a measure of a Prestige Brand's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 29.66% |
| Gross profit TTM | $627.9 million |
| Return on assets TTM | 6.42% |
| Return on equity TTM | 13.5% |
| Profit margin | 18.6% |
| Book value | $33.22 |
| Market Capitalization | $3.5 billion |
TTM: trailing 12 months
We're not expecting Prestige Brand to pay a dividend over the next 12 months.
Over the last 12 months, Prestige Brand's shares have ranged in value from as little as $56.344 up to $75.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Prestige Brand's is 0.491. This would suggest that Prestige Brand's shares are less volatile than average (for this exchange).
Prestige Consumer Healthcare Inc. , together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc.
Learn how to invest in Cathie Wood’s ARK Venture Fund in 5 easy steps.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.